AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Greenleaf (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated March 3, 2014.
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
INDEMNIFICATION AGREEMENT (this “Agreement”) dated as of July [___], 2016 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and [___________](“Indemnitee”):
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo AG, Baarerstrasse 22, 6300 Zug, (“Sucampo”), and Peter Lichtlen (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated October 21, 2014.
